Ana Barac, MD, PhD, specializes in non-invasive cardiology with a focus on cardiac imaging, echocardiography and cardiac MRI. Her clinical and research interests are cardio-oncology and cardiovascular disease prevention.
Dr. Barac is a full-time faculty member of the Cardiology department at MedStar Washington Hospital Center. She is director of MedStar Heart & Vascular Institute's Cardio-Oncology Program and medical director of the Cardiac Rehabilitation Program.
Dr. Barac is on the editorial boards of the Journal of the American College of Cardiology (JACC) and the Journal of Cardiovascular Translational Research. She is a reviewer for a number of prestigious medical journals, and publishes articles in numerous peer-reviewed journals.
Dr. Barac frequently presents her work at national and international conferences, including the American College of Cardiology and the American Heart Association. She is fluent in English, Italian, Spanish and Croatian.
Dr. Barac has a background in molecular signaling. She was a research fellow in the Oral and Pharyngeal Cancer Branch, National Institute for Dental and Craniofacial Research, National Institutes of Health, from 2000 to 2003. Prior to that, she was a visiting fellow in Ludwig Institute for Cancer research in Uppsala, Sweden. As a member of the American Society of Echocardiography, Dr. Barac is part of the writing group for the society's Guidelines for Echocardiographic Evaluation and Treatment of Patients During and After Cancer Therapy.
Dr. Barac serves on the American College of Cardiology's Early Career Professionals Council as well as on the Women in Cardiology Council.
PILOT STUDY SEEKS RIGHT BALANCE BETWEEN SURVIVAL AND SAFETY: Dr. Barac, along with Dr. Sandra Swain and Dr. Filipa Lynce, have teamed up to launch SAFE-HEaRt, an investigator-initiated study looking at how to maximize the use of HER2-targeted therapy for breast cancer, while minimizing adverse affects on the heart.